We revealed that AS-tDR-007333 could promote the malignancy of NSCLC cells by targeting at oncogenic MED29 through activating HSPB1- and ELK4-mediated epigenetic and transcriptional regulation axes. Here, ELK4 is linked to non-small cell lung carcinoma.